As the world struggles with the ongoing COVID-19 pandemic, unprecedented obstacles
have continuously been traversed as new SARS-CoV-2 variants continually emerge …

The emergence of new SARS-CoV-2 Omicron variant of concern (OV) has exacerbated the
COVID-19 pandemic because of a large number of mutations in the spike protein …

The spike protein (S-protein) is a crucial part of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), with its many domains responsible for binding, fusion, and …

The most recent Omicron variant of SARS-CoV-2 has caused global concern and anxiety.
The only thing certain about this strain, with a large number of mutations in the spike protein …

The receptor-binding domain (RBD) is the essential part in the Spike-protein (S-protein) of
SARS-CoV-2 virus that directly binds to the human ACE2 receptor, making it a key target for …

The emergence of Omicron SARS-CoV-2 subvariants (BA. 1, BA. 2, BA. 4, and BA. 5), with
an unprecedented number of mutations in their receptor-binding domain (RBD) of the spike …

Coronavirus disease (COVID-19) is an infectious disease that is caused by a highly
contagious and severe acute respiratory syndrome—coronavirus 2 (SARS-CoV-2). This …

The attachment of the spike protein in SARS-CoV-2 to host cells and the initiation of viral
invasion are two critical processes in the viral infection and transmission in which the …

LCB1 is a computationally designed 56-mer miniprotein targeting the spike (S) receptor-
binding motif of SARS-CoV-2 with high potent activity (Science, 2020; Cell host microbe …

The COVID-19 pandemic has underscored the critical need for the advancement of
diagnostic and therapeutic platforms. These platforms rely on the rapid development of …